Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Chiron has received a license for its new meningococcal B vaccine for New Zealand

Chiron developed the vaccine, in close collaboration with the New Zealand Ministry of Health and the Norwegian Institute of Public Health, to protect against the specific meningococcal B strain responsible for a 13-year epidemic in the country.

7 Jul 2004

Nanotechnology-based applications are accelerating the development of nanomedicine

With the potential for targeted therapy, and therefore reduced side effects, nanomedicine holds the promise of significantly improving quality of life parameters.

5 Jul 2004

Amid unprecedented global prosperity, the world’s poor were more vulnerable now than ever

The 43 speakers in two meetings today -- on resources mobilization and an enabling environment for poverty eradication -- recognized that the primary responsibility for development in the least developed countries (LDCs) rested with those nations themselves.

2 Jul 2004

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.

1 Jul 2004

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.

1 Jul 2004

Alcon updates filing status of RETAANE® new drug application

Alcon, Inc. has announced that it has filed the second portion of its “rolling” New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for RETAANE® 15mg (anecortave acetate for depot suspension)

30 Jun 2004

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford University's Therapeutic Antibody Centre (TAC) has received a Manufacturer's Authorisation (Investigational Medicinal Products) from the Medicines and Healthcare Products Regulatory Agency (MHRA).

29 Jun 2004

Delphi expands medical footprint

Delphi Medical Systems Corporation, a subsidiary of Delphi Corporation, recently signed a licensing agreement with Switzerland-based medical device company Debiotech, S.A.

29 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries

25 Jun 2004

“On health care, Paul Martin’s credibility gap continues to widen,” says Harper

Conservative leader Stephen Harper visited Sault Ste. Marie today and said Paul Martin should have said no to Ontario Premier Dalton McGuinty and Liberal campaign chair David Herle about their actual plans for health care instead of manufacturing a false debate on yet-to-be announced health reforms.

23 Jun 2004

Pharmaxis completes interim analysis on Bronchitol study

Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.

21 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries, according to the Pan American Health Organization (PAHO).

15 Jun 2004

Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel them to coexist and complement each other.

10 Jun 2004

New packaging could save lives

Because they are easier for adults to open, the containers will discourage the decanting of medicines into unsafe packaging – a practice which currently causes an estimated 10,000 cases/year of accidental poisoning in the UK, mostly involving small children.

3 Jun 2004

150 top scientists debate and offer expert advice on cutting edge vaccine research

More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.

3 Jun 2004

Model of the central nervous system will allow oncologists and neurosurgeons to target tumours more effectively

A larger-than-life model of the human central nervous system including the brain and spinal cord, which will allow oncologists and neurosurgeons to target tumours more effectively, will be among a range of student projects on display at an event at The University of Nottingham this week.

2 Jun 2004

Genes that allow nerve cells to communicate may have come from bacteria eons ago

Some of the genes that allow nerve cells and some other types of cells to send elaborate chemical messages to each other appear to have been transferred to animals or their immediate ancestors from bacteria eons ago.

2 Jun 2004

New medical patent covering the generation of genetically enhanced therapeutic antigens

Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.

2 Jun 2004

First Consulting Group announces expansion of relationship with AstraZeneca

First Consulting Group, Inc. has announced that it has expanded its long-standing relationship with AstraZeneca. FCG will help AstraZeneca deliver a new off-the-shelf document management solution and upgrade its manufacturing site document management system to FirstDoc™.

2 Jun 2004

Manufacturing News and Research

Further Reading

Chiron has received a license for its new meningococcal B vaccine for New Zealand

Nanotechnology-based applications are accelerating the development of nanomedicine

Amid unprecedented global prosperity, the world’s poor were more vulnerable now than ever

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Alcon updates filing status of RETAANE® new drug application

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Delphi expands medical footprint

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

“On health care, Paul Martin’s credibility gap continues to widen,” says Harper

Pharmaxis completes interim analysis on Bronchitol study

WHO removes two antiretroviral products from the WHO List of prequalified products

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

New packaging could save lives

150 top scientists debate and offer expert advice on cutting edge vaccine research

Model of the central nervous system will allow oncologists and neurosurgeons to target tumours more effectively

Genes that allow nerve cells to communicate may have come from bacteria eons ago

New medical patent covering the generation of genetically enhanced therapeutic antigens

First Consulting Group announces expansion of relationship with AstraZeneca

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News